These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12652515)

  • 1. Design techniques for stated preference methods in health economics.
    Carlsson F; Martinsson P
    Health Econ; 2003 Apr; 12(4):281-94. PubMed ID: 12652515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical investigation of experimental design properties of discrete choice experiments in health care.
    Viney R; Savage E; Louviere J
    Health Econ; 2005 Apr; 14(4):349-62. PubMed ID: 15712274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination.
    Hall J; Kenny P; King M; Louviere J; Viney R; Yeoh A
    Health Econ; 2002 Jul; 11(5):457-65. PubMed ID: 12112494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using discrete choice experiments to value health care programmes: current practice and future research reflections.
    Ryan M; Gerard K
    Appl Health Econ Health Policy; 2003; 2(1):55-64. PubMed ID: 14619274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the axiom of completeness in health care.
    Ryan M; San Miguel F
    Health Econ; 2003 Apr; 12(4):295-307. PubMed ID: 12652516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experiment on simplifying conjoint analysis designs for measuring preferences.
    Maddala T; Phillips KA; Reed Johnson F
    Health Econ; 2003 Dec; 12(12):1035-47. PubMed ID: 14673812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothetical bias, cheap talk, and stated willingness to pay for health care.
    Ozdemir S; Johnson FR; Hauber AB
    J Health Econ; 2009 Jul; 28(4):894-901. PubMed ID: 19464743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
    Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
    Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory.
    Lancsar E; Savage E
    Health Econ; 2004 Sep; 13(9):901-7. PubMed ID: 15362181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods.
    Ryan M; Scott DA; Donaldson C
    J Health Econ; 2004 Mar; 23(2):237-58. PubMed ID: 15019754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between reliability and size of willingness-to-pay values: a qualitative insight.
    Smith RD
    Health Econ; 2007 Feb; 16(2):211-6. PubMed ID: 16929470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robustness of optimal design of fMRI experiments with application of a genetic algorithm.
    Maus B; van Breukelen GJ; Goebel R; Berger MP
    Neuroimage; 2010 Feb; 49(3):2433-43. PubMed ID: 19833212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the monetary value of health care: lessons from environmental economics.
    Hanley N; Ryan M; Wright R
    Health Econ; 2003 Jan; 12(1):3-16. PubMed ID: 12483757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness-to-pay for reducing fatal accident risk in urban areas: an Internet-based Web page stated preference survey.
    Iragüen P; de Dios Ortúzar J
    Accid Anal Prev; 2004 Jul; 36(4):513-24. PubMed ID: 15094403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deriving welfare measures in discrete choice experiments: a comment to Lancsar and Savage (1).
    Ryan M
    Health Econ; 2004 Sep; 13(9):909-12; discussion 919-24. PubMed ID: 15362182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threats to the estimation of benefit: are preference elicitation methods accurate?
    Lloyd AJ
    Health Econ; 2003 May; 12(5):393-402. PubMed ID: 12720256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of stated preference methods for estimating monetary values.
    Ryan M
    Health Econ; 2004 Mar; 13(3):291-6. PubMed ID: 14981653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
    Retout S; Mentré F; Bruno R
    Stat Med; 2002 Sep; 21(18):2623-39. PubMed ID: 12228881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.